AI

SK hynix Raises $26.5B in Nasdaq Listing on AI Chip Demand

The South Korean memory chip supplier to Nvidia priced shares above Saudi Aramco's 2019 debut, second only to SpaceX's recent record.

Omega Editorial· July 10, 2026· 3 min read

South Korean semiconductor manufacturer SK hynix completed one of the largest stock offerings in history on Friday, raising $26.5 billion through a Nasdaq listing that capitalizes on surging demand for AI infrastructure components.

The company priced 177.9 million American depositary shares at $149 each, with each ADS representing one-tenth of a standard share. According to U.S. media reports, the offering attracted more than seven times the available shares, signaling strong investor appetite despite recent volatility in technology stocks.

The Guardian first reported the details of the listing, which marks the second-largest public offering on record after SpaceX's $75 billion IPO last month. SK hynix's raise surpassed Saudi Aramco's $25.6 billion debut in 2019 and Alibaba's $21.8 billion New York listing.

AI Boom Drives Memory Chip Profits

SK hynix supplies high-bandwidth memory chips to Nvidia and other manufacturers building AI datacenters. The company's Seoul-traded shares have climbed more than 220% this year as global investment in artificial intelligence infrastructure accelerates. Its market capitalization exceeded $1 trillion in May, joining Samsung Electronics and Micron in reaching that threshold—a milestone previously dominated by American firms.

The three companies control the global market for high-bandwidth memory, specialized components that work alongside processors in AI servers. As manufacturers prioritize these lucrative products, shortages of standard memory chips have emerged, contributing to Apple's recent price increases for MacBooks and iPads.

Funding Expansion Plans

SK hynix stated it will direct proceeds toward constructing the first fabrication facility at a new semiconductor cluster in Yongin, near Seoul, and building an advanced packaging plant in Cheongju. The company is also participating in an 800 trillion won public-private initiative to develop a chip manufacturing hub in southwestern South Korea.

Counterpoint Research analyst MS Hwang told AFP the capital infusion supports SK hynix's ambition to challenge Samsung's volume leadership in memory chips while maintaining its edge in high-bandwidth memory technology.

Shares in SK hynix rose 2.7% on Seoul's Kospi index following the pricing announcement. BofA Securities, Citigroup Global Markets, Goldman Sachs (Asia), and JP Morgan Securities led the offering.

Why It Matters

The successful raise demonstrates that institutional investors remain willing to fund semiconductor capacity expansion despite concerns about AI spending returns and elevated tech valuations. For South Korea, the capital flowing into its chip sector represents both economic opportunity and pressure—the country faces decisions about deploying tax windfalls from the boom while workers at Samsung and other firms push for higher compensation tied to industry profits.

Details of the SK hynix listing were first reported by The Guardian.

#sk hynix#semiconductor manufacturing#nasdaq listing#high-bandwidth memory#ai infrastructure#south korea

This is an original analysis by the Omega editorial team. Source reporting: AI Watch.

Want systems like this working for your business?

Book a Call

More in AI

AI· 4 min read

NVIDIA Shows How to Build 500K Synthetic Financial Headlines

Iterative generation-deduplication loop solves the diversity problem that makes single-pass synthetic data fail for rare financial events.

Via AI Watch · Jul 10, 2026
AI· 3 min read

Facebook Permanently Bans Minnesota Radio CEO After AI Flags News Posts

Joel Glaser lost access to his personal account and a public history project after Meta's automated system allegedly confused educational content with policy violations.

Via AI Watch · Jul 10, 2026
AI· 3 min read

OpenAI AGI Deployment Chief Fidji Simo Steps Down

The executive will transition to a part-time advisory role after months of medical leave for a chronic neuroimmune condition.

Via WIRED · Jul 9, 2026